๐ฐ Elsevier News
Page 28 - Elsevier News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Elsevier. Real-time updates on events, politics, business and more.
November 30, 2023
Neuroimaging exposes alterations in connectivity among individuals dealing with obsessive-compulsive disorder (OCD), stated study.
November 30, 2023
Phase 3b DAYLIGHT study being presented at ESG 2023 demonstrated fezolinetant 45 mg achieved statistically significant reductions in the frequency and severity...
November 30, 2023
The 10th international conference on sustainability, SUSCON X, concluded at IIM Shillong, marking a significant milestone in addressing the global sustainability challenges. Learn about the conference highlights and research presentations.
November 30, 2023
A first-line therapy for obsessive-compulsive disorder (OCD) reshapes connectivity of the brain, according to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier.
November 30, 2023
Discover creating microchips, from silicon to electronic devices, encompassing history, fabrication phases, and technological progress.
November 30, 2023
Everyone should get quality care, no matter the color of their skin. However, implicit bias, micro-aggressions, and a lack of cultural understanding persist, leading to oppression and unequal treatment in healthcare.
November 29, 2023
Benjamin K. Sovacoolโs profile on The Conversation
November 29, 2023
Steven Griffithsโ profile on The Conversation
November 28, 2023
Chefs and restaurants could boost the popularity of plant-based dishes by giving them more appealing names - such as a Juicy American burger, report experts at the University of Queensland.
November 28, 2023
<p>Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023) observed that although cardiac rehabilitation benefits diverse groups of patients and affords the most cost-effective prevention for recurrent events, it is grossly underutilized globally. They concluded that access is the hardest obstacle for patients to overcome. Contributions from the symposium are included in ...